Holen Sie sich die Stockscreener-App
2.12
3.41%
0.07
C 4 Therapeutics Inc Aktie (CCCC) Neueste Nachrichten
What are analysts’ price targets for C4 Therapeutics Inc. in the next 12 monthsWealth Building Trend Scanner For Smart Trading - jammulinksnews.com
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Xilio Therapeutics Awards $87K Worth of Stock Options in Key Employee Inducement Plan - Stock Titan
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Protara Therapeutics Grants $45K Worth of Stock Options and RSUs to Strategic New Employees - Stock Titan
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Akebia Therapeutics Awards $880K Worth of Stock Options in Strategic New Employee Package - Stock Titan
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Intellia Therapeutics Expands Team with Strategic Stock Grants Worth 18,200 Shares - Stock Titan
Does C4 Therapeutics Inc. stock perform well during market downturnsAdvanced Screener Report With High Returns - jammulinksnews.com
What is the risk reward ratio of investing in C4 Therapeutics Inc. stockChart Pattern Trend Scanner With Low Risk - jammulinksnews.com
Here's What Analysts Are Forecasting For C4 Therapeutics, Inc. (NASDAQ:CCCC) After Its First-Quarter Results - 富途牛牛
New Product Launches: Will They Boost C4 Therapeutics Inc. Stock in 2025Community Strategy With High Win Rate Backtested - metal.it
What makes C4 Therapeutics Inc. stock price move sharplySwing Trade Entry With Volume Triggers Released - metal.it
Published on: 2025-07-29 21:44:21 - metal.it
Is C4 Therapeutics Inc. stock overvalued or undervaluedGet timely alerts on market opportunities - jammulinksnews.com
What is the dividend policy of C4 Therapeutics Inc. stockMaximize gains with proven stock analysis - jammulinksnews.com
Is C4 Therapeutics Inc. a growth stock or a value stockRecord-setting profit potential - jammulinksnews.com
What are the latest earnings results for C4 Therapeutics Inc.Discover stocks with superior performance - jammulinksnews.com
Is it the right time to buy C4 Therapeutics Inc. stockInvest confidently with professional market insights - jammulinksnews.com
How does C4 Therapeutics Inc. generate profit in a changing economyGet daily expert analysis on top stocks - jammulinksnews.com
What are C4 Therapeutics Inc. company’s key revenue driversRapid-fire capital growth - jammulinksnews.com
Why is C4 Therapeutics Inc. stock attracting strong analyst attentionMaximize gains with data-driven trading alerts - jammulinksnews.com
When is C4 Therapeutics Inc. stock expected to show significant growthBuild wealth steadily with proven stock picks - jammulinksnews.com
Why C4 Therapeutics Inc. stock attracts strong analyst attentionFree Exclusive Stock Market Insights - beatles.ru
What analysts say about C4 Therapeutics Inc. stock outlookFree Predictions - metal.it
What analysts say about C4 Therapeutics Inc. stockExceptional stock performance - PrintWeekIndia
Is C4 Therapeutics Inc. a good long term investmentExceptional financial outcomes - PrintWeekIndia
C4 Therapeutics Inc. Stock Analysis and ForecastMarket-crushing stock picks - PrintWeekIndia
What drives C4 Therapeutics Inc. stock priceMarket-beating performance - jammulinksnews.com
0.93%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):